Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Duminuco

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Journal of Clinical Medicine|March 29, 2023
Myelofibrosis and Survival Prognostic Models: A Journey between Past and FutureAndrea Duminuco, Antonella Nardo, Gaetano Giuffrida, et al.
Hematology Reports|October 24, 2023
Transient Leukemoid Reaction from T-Cell Large Granular Lymphocytes Post Autologous Stem Cell Transplant in a Patient Affected by Hodgkin LymphomaAndrea Duminuco, Marina Parisi, Giulio Antonio Milone, et al.
Hematology Reports|June 27, 2023
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the <i>MPL</i> Gene: Two Case ReportsMaria Stella Pennisi, Sandra Di Gregorio, Elena Tirrò, et al.
Cancers|February 24, 2024
Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin LymphomaAndrea Duminuco, Gabriella Santuccio, Annalisa Chiarenza, et al.
Biomolecules|January 28, 2026
BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune DisordersAndrea Duminuco, Paola De Luca, Gaia Stanzione, et al.
Hematology Reports|April 25, 2022
<i>Saprochete capitata</i>: Emerging Infections from Uncommon Microorganisms in Hematological DiseasesAndrea Duminuco, Calogero Vetro, Cinzia Maugeri, et al.
Journal of Clinical Medicine|January 21, 2023
<i>Leishmania</i> Infection during Ruxolitinib Treatment: The Cytokines-Based Immune Response in the Setting of Immunocompromised PatientsAndrea Duminuco, Salvatore Scarso, Alessandra Cupri, et al.
Cancers|May 14, 2022
Target Therapy for Extramedullary Relapse of <i>FLT3</i>-ITD Acute Myeloid Leukemia: Emerging Data from the FieldAndrea Duminuco, Cinzia Maugeri, Marina Parisi, et al.
Biomolecules|December 23, 2023
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological CancersSebastiano Giallongo, Andrea Duminuco, Ilaria Dulcamare, et al.
Frontiers in Oncology|March 3, 2023
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccineGiuseppe A Palumbo, Daniela Cambria, Enrico La Spina, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|March 29, 2023
Myelofibrosis and Survival Prognostic Models: A Journey between Past and FutureAndrea Duminuco, Antonella Nardo, Gaetano Giuffrida, et al.
Hematology Reports|October 24, 2023
Transient Leukemoid Reaction from T-Cell Large Granular Lymphocytes Post Autologous Stem Cell Transplant in a Patient Affected by Hodgkin LymphomaAndrea Duminuco, Marina Parisi, Giulio Antonio Milone, et al.
Hematology Reports|June 27, 2023
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the <i>MPL</i> Gene: Two Case ReportsMaria Stella Pennisi, Sandra Di Gregorio, Elena Tirrò, et al.
Cancers|February 24, 2024
Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin LymphomaAndrea Duminuco, Gabriella Santuccio, Annalisa Chiarenza, et al.
Biomolecules|January 28, 2026
BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune DisordersAndrea Duminuco, Paola De Luca, Gaia Stanzione, et al.
Hematology Reports|April 25, 2022
<i>Saprochete capitata</i>: Emerging Infections from Uncommon Microorganisms in Hematological DiseasesAndrea Duminuco, Calogero Vetro, Cinzia Maugeri, et al.
Journal of Clinical Medicine|January 21, 2023
<i>Leishmania</i> Infection during Ruxolitinib Treatment: The Cytokines-Based Immune Response in the Setting of Immunocompromised PatientsAndrea Duminuco, Salvatore Scarso, Alessandra Cupri, et al.
Cancers|May 14, 2022
Target Therapy for Extramedullary Relapse of <i>FLT3</i>-ITD Acute Myeloid Leukemia: Emerging Data from the FieldAndrea Duminuco, Cinzia Maugeri, Marina Parisi, et al.
Biomolecules|December 23, 2023
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological CancersSebastiano Giallongo, Andrea Duminuco, Ilaria Dulcamare, et al.
Frontiers in Oncology|March 3, 2023
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccineGiuseppe A Palumbo, Daniela Cambria, Enrico La Spina, et al.
Pageof 8